GLP-1R Antibody - BSA Free

Immunohistochemistry: GLP-1R Antibody [NBP1-97308] - Analysis of GLP1R in mouse pancreas using DAB with hematoxylin counterstain.

Western Blot: GLP-1R Antibody [NBP1-97308] - Liraglutide reduces apoptosis of hCMSCs via PKA/i2-catenin pathway. The expression of GLP-1R and apoptotic proteins Bax, Bcl-2, cleaved caspase-9, and cleaved caspase-3 were detected by western blot with Si-GLP-1R and liraglutide. Image collected and cropped by Citeab from the following publication (Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/-catenin. Stem Cell Res Ther (2020) licensed under a CC-BY license.

Simple Western: GLP-1R Antibody [NBP1-97308] - Simple Western lane view shows a specific band for GLP-1R in 0.5 mg/ml of Human Pancreas (left) and Mouse Pancreas (right) lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system. * Non-specific interaction with the 230 kDa Simple Western standard may be seen with this antibody

Western Blot: GLP-1R Antibody [NBP1-97308] - Total protein from Human and Mouse brain and SHSY-5Y cells was separated on a 12% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 2.0 ug/ml anti-GLP1R in 1% non-fat milk in TBST and detected with an anti-rabbit HRP secondary antibody using chemiluminescence.

Western Blot: GLP-1R Antibody [NBP1-97308] - Expression of GLP-1R in three MSCs at different time points under the stimulation of LPS. The expression of GLP-1R in hCMSCs, hBMSCs, and hAMSCs in the control group and in 30 ug/mL LPS stimulation for 24 h, 48 h, and 72 h at protein. Fluorescence intensity of GLP-1R in hCMSCs Image collected and cropped by Citeab from the following publication (Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/-catenin. Stem Cell Res Ther (2020) licensed under a CC-BY license.

Immunocytochemistry/Immunofluorescence: GLP-1R Antibody [NBP1-97308] - GLP1R-1 antibody was tested in HeLa cells with FITC (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).

Immunohistochemistry-Paraffin: GLP-1R Antibody [NBP1-97308] - Tissue section of mouse pancreas using 1:200 dilution of rabbit anti-GLP1R antibody. The staining was developed with HRP labeled anti-rabbit IgG secondary antibody and DAB reagent, and nuclei of cells were counter-stained with hematoxylin. This GLP1R antibody primarily generated a specific membrane cytoplasmic staining of apparently beta cells in the Islets of Langerhans. The cells of lobular/inter-lobular ducts and the acinar cells were largely negative for GLP1R.

Western Blot: GLP-1R Antibody [NBP1-97308] - Analysis of GLP1R in human pancreas cell lysate.

Immunocytochemistry/Immunofluorescence: GLP-1R Antibody [NBP1-97308] - Neuro2a cells were fixed for 10 minutes using 10% formalin and then permeabilized for 5 minutes using 1X PBS + 0.05% Triton-X100. The cells were incubated with anti-GLP-1R at 5 ug/ml overnight at 4C and detected with an anti-rabbit Dylight 488 (Green) at a 1:500 dilution. Alpha tubulin (DM1A) NB100-690 was used as a co-stain at a 1:1000 dilution and detected with an anti-mouse Dylight 550 (Red) at a 1:500 dilution. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.

Immunohistochemistry-Paraffin: GLP-1R Antibody [NBP1-97308] - Tissue section of mouse pancreas using 1:200 dilution of rabbit anti-GLP1R antibody. The staining was developed with HRP labeled anti-rabbit IgG secondary antibody and DAB reagent, and nuclei of cells were counter-stained with hematoxylin. This GLP1R antibody primarily generated a specific membrane cytoplasmic staining of apparently beta cells in the Islets of Langerhans.

Western Blot: GLP-1R Antibody - BSA Free [NBP1-97308] - Liraglutide reduces apoptosis of hCMSCs via PKA/ beta -catenin pathway. a Western blot & b RT-qPCR verify the knockdown effects of three Si-GLP-1R in hCMSCs. c, d Western blot was used to detect of beta -catenin & p-beta -catenin expression under the stimulation of LPS by adding 20 μM H89 or 100 nM Si-GLP-1R & liraglutide. e The expression of apoptotic proteins Bax, Bcl-2, cleaved caspase-9, & cleaved caspase-3 was detected by western blot with PKA inhibitor H89 & liraglutide. f The expression of GLP-1R & apoptotic proteins Bax, Bcl-2, cleaved caspase-9, & cleaved caspase-3 were detected by western blot with Si-GLP-1R & liraglutide. Error bars represent mean ± SD from three independent experiments. Compared with Si-con group, ***P < 0.001 Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32429994), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

• Reactivity: Hu, Mu, Rt, Ca
• Applications: WB, Simple Western, DB, ICC/IF, IHC, KD
• Clonality: Polyclonal
• Host: Rabbit
• Conjugate: Unconjugated
• Format: BSA Free
• Concentration: 1.0 mg/ml

GLP-1R Antibody - BSA Free Summary

• Immunogen: A synthetic peptide made to an internal portion of the human GLP1R protein (between residues 250-350) [UniProt P43220]
• Localization: Cell membrane; Multi-pass membrane protein.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Rabbit
• Gene: GLP1R
• Purity: Immunogen affinity purified

Applications/Dilutions

• Dilutions:
  • Dot Blot reported in scientific literature (PMID 27435156)
  • Immunocytochemistry/ Immunofluorescence 1:100
  • Immunohistochemistry 1:200
  • Immunohistochemistry-Paraffin 1:200 - 1:400
  • Knockdown Validated reported in scientific literature (PMID 31900217)
  • Simple Western 1:100
  • Western Blot 1:1000
• Application Notes: In WB, a band is seen ~53kDa representing GLP1R. In ICC/IF, membrane staining was observed in HeLa cells. In IHC-P, strong membrane staining was observed in mouse pancreas tissue. Prior to immunostaining paraffin tissues, antigen retrieval with sodium citrate buffer (pH 6.0) is recommended. In Simple Western only 10 - 15 uL of the recommended dilution is used per data point.
  See Simple Western Antibody Database for Simple Western validation: Tested in Human Pancreas and Mouse Pancreas lysate 0.5 mg/mL, separated by Size, antibody dilution of 1:100. Separated by Size-Wes, Sally Sue/Peggy Sue.
• Control Peptide:

  GLP-1R Peptide (NBP1-97308PEP)

Reactivity Notes

Rat reactivity reported in scientific literature (PMID: 27435156). Canine reactivity reported in scientific literature (PMID: 25747753).

Packaging, Storage & Formulations

• Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Buffer: PBS
• Preservative: 0.02% Sodium Azide
• Concentration: 1.0 mg/ml
• Purity: Immunogen affinity purified

Alternate Names for GLP-1R Antibody - BSA Free

• GLP-1 receptor
• GLP1R
• GLP-1R
• GLP-1-R
• glucagon-like peptide 1 receptor
• MGC138331

Background

GLP1R (Glucagon-like peptide 1 receptor) is an incretin hormone produced in the intestine that is released in response to food intake. GLP1R plays an important role in maintaining blood glucose homeostasis and has been suggested to affect the feelings of satiety or hunger, sensation of glucose levels and control of glucagon sensitivity of islets. In addition, desensitization of GLP1R on pancreatic beta-cells is one of the causes of non insulin-dependent diabetes mellitus (NIDDM), and GLP1R is starting to play an increasingly important role in endocrine gastrointestinal tumor management.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for GLP-1R Antibody (NBP1-97308)(29)

Publications using NBP1-97308

• Amany E. Nofal, Hind S. AboShabaan, Walaa A. Fadda, Rafik E. Ereba, Sherin M. Elsharkawy, Heba M. Hathout, Jérôme Eeckhoute L-carnitine and Ginkgo biloba Supplementation In Vivo Ameliorates HCD-Induced Steatohepatitis and Dyslipidemia by Regulating Hepatic Metabolism Cells 2024-04-23 [PMID: 38727268]
• Cantacorps L, Coull BM, Falck J et al. Gut-derived peptide hormone receptor expression in the developing mouse hypothalamus PLOS ONE 2023-08-17 [PMID: 37590249] (Mouse, Western Blot)
• You F, Li C, Zhang S et al. Sitagliptin inhibits the survival, stemness and autophagy of glioma cells, and enhances temozolomide cytotoxicity Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023-03-24 [PMID: 36966667] (WB, Human)
  
  Details:
  Dilution used in WB 1:1000
• Yan C, Ma X, Lam SM et al. Exendin-4 attenuates atherosclerosis progression via controlling hematopoietic stem/progenitor cell proliferation Journal of molecular cell biology 2023-03-02 [PMID: 36866528]
• Wang K, Cui X, Li F et al. Glucagon receptor blockage inhibits beta -cell dedifferentiation through FoxO1 American journal of physiology. Endocrinology and metabolism 2022-11-16 [PMID: 36383639] (IHC-P, WB, Mouse)
• Li R, Ye Z, She D et al. Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120/ABHD6 Drug design, development and therapy 2022-10-12 [PMID: 36238196] (IHC-P, Mouse)
• Li R, She D, Ye Z et al. Glucagon-Like Peptide 1 Receptor Agonist Improves Renal Tubular Damage in Mice with Diabetic Kidney Disease Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022-04-29 [PMID: 35519661] (Mouse, Western Blot)
• Meurot C, Martin C, Sudre L et al. Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis Scientific reports 2022-01-28 [PMID: 35091584] (IF/IHC, Human)
• Li Y, Xu B, Yang J Et al. Liraglutide protects against lethal renal ischemia-reperfusion injury by inhibiting high-mobility group box 1 nuclear-cytoplasmic translocation and release Pharmacological Research 2021-09-01 [PMID: 34481074] (IF/IHC, WB, Mouse)
• Mieczkowska A, Bouvard B, Legrand E, Mabilleau G [Gly2]-GLP-2, But Not Glucagon or [D-Ala2]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures Frontiers in endocrinology 2021-08-04 [PMID: 34421828] (WB)
• Sho H, Fukui K, Yoneda S et al. Insulinoma induces a hyperinsulinemia-mediated decrease of GLUT2 and GLP1 receptor in normal pancreatic beta-cells Biochem Biophys Res Commun 2020-11-13 [PMID: 33199025] (WB, Mouse)
  
  Details:
  Western blot analysis performed on Min6 cells cultured in insulin
• Deng H, Yang F, Ma X et al. Long-Term Liraglutide Administration Induces Pancreas Neogenesis in Adult T2DM Mice Cell Transplant 2020-06-26 [PMID: 32584149] (ICC/IF, Mouse)
• Timper K, Del Rio-Martin A, Cremer AL et al. GLP-1 Receptor Signaling in Astrocytes Regulates Fatty Acid Oxidation, Mitochondrial Integrity, and Function Cell Metab. 2020-06-02 [PMID: 32433922] (WB, Mouse)
• Yang X, Ma X, Don O et al. Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/beta-catenin Stem Cell Res Ther 2020-05-19 [PMID: 32429994] (WB, Human)
• Chaudhari S, Yazdizadeh Shotorbani P, Tao Y et al. Inhibition of interleukin-6 on matrix protein production by glomerular mesangial cells and its pathway involved Am. J. Physiol. Renal Physiol. 2020-05-11 [PMID: 32390515]
• Feng Y, Wang L, Ma X et al. Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/beta-catenin signaling pathway Stem Cell Res Ther 2020-01-03 [PMID: 31900217] (KD, WB, Mouse, Human)
• Cappetta D, Ciuffreda L, Cozzolino A et al. Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension Oxidative Medicine and Cellular Longevity 2019-01-10 [PMID: 30774748] (IF/IHC, Rat)
• Zhou D, Chen YW, Zhao ZH et al. Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression Exp. Mol. Med. 2018-12-03 [PMID: 30510243] (WB, IHC-P, Human)
• Zhou Y, Li Z, Cao X et al. Exendin-4 Improves Behaviorial Deficits via GLP-1/GLP-1R Signaling following Partial Hepatectomy. Oncogenesis. 2018-11-12 [PMID: 30408479] (IF/IHC, Rat)
• Rocha-Ferreira E, Poupon L, Zelco A et al. Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy Brain 2018-08-24 [PMID: 30165597] (IF/IHC, Mouse)
• GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control. Nomiyama T, Yanase, T Expert Rev Endocrinol Metab [PMID: 30058925]
• Iwaya C, Nomiyama T, Komatsu S et al. Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates breast cancer growth by inhibiting NF-kB activation. Endocrinology. 2017-10-13 [PMID: 29045658] (IHC-P, Human)
• Wenjing H, Shuang Y, Weisong L, Haipeng X. Exendin-4 does not modify growth or apoptosis of human colon cancer cells. Endocr. Res. 2017-03-20 [PMID: 28318339] (IF/IHC, Human)
• He W, Yu S, Wang L et al. Exendin-4 inhibits growth and augments apoptosis of ovarian cancer cells. Mol. Cell. Endocrinol. 2016-08-03 [PMID: 27496641] (IF/IHC, Human)
• Steven S, Jurk K, Kopp M et al. Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitrosative and oxidative stress, systemic inflammation and platelet activation in endotoxaemic mice Br. J. Pharmacol. 2016-07-19 [PMID: 27435156] (WB, Cytometric Bead Assay Standard, Human, Mouse, Rat)
• Tsutsumi Y, Nomiyama T, Kawanami T et al. Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth. PLoS One 2015-01-01 [PMID: 26439622] (IF/IHC)
• Ihara M, Asanuma H, Yamazaki S et al. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2015-05-15 [PMID: 25747753]
• Nomiyama T, Kawanami T et al. Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth. Diabetes 2014-01-11 [PMID: 24879833] (IF/IHC, Human)
• Kedees MH, Guz Y, Grigoryan M et al. Functional activity of murine intestinal mucosal cells is regulated by the glucagon-like peptide-1 receptor Peptides. 2013 Aug 6. pii: S0196-9781(13)00262-3. 2013-08-06 [PMID: 23927844] (WB, Mouse)

FAQs for GLP-1R Antibody (NBP1-97308). (Showing 1 - 2 of 2 FAQs).

1. If possible I would like to get more information on the immunogen used to rase NBP1-97308.
   • The immunogen for NBP1-97308 is considered to be proprietary; however the range of amino acids where the immunogen is located is between residues 250-350. [UniProt P43220].
2. I am wondering if I can use it for in situ PLA to test interaction with a GPCR scaffolding protein, i.e. the secondary antibody should be exposed to the cytosol. Is this antibody suitable?
   • NBP1-97308 recognizes an extracellular portion of GLP1R so it does not seem that it is suitable for your studies, as described.

Bioinformatics

• Gene Symbol: GLP1R
• Entrez:
  • 2740(Human)
• Uniprot:
  • P43220()